Skip to main content
. 2015 Feb 3;10(4):282–292. doi: 10.1080/15592294.2015.1006505

Table 1.

Selected characteristics of PLCO and ATBC cases and controls

 
PLCO1
 
 
ATBC2
 
  Cases
Controls
    Cases
Controls
 
Characteristic N (%) N (%) P3 Characteristic N (%) N (%) P3
Total 215 (100.0) 436 (100.0) NA Total 191 (100.0) 575 (100.0) NA
Gender                      
Male 139 (64.7) 291 (66.7)   Male 191 (100.0) 575 (100.0) NA
Female 76 (35.4) 145 (33.3)   -          
          0.60            
Age at randomization (years)                      
-           49-54 75 (39.3) 230 (40.0)  
55–59 73 (34.0) 146 (33.5)   55–59 66 (34.6) 194 (33.7)  
60–64 74 (34.4) 149 (34.2)   60–64 41 (21.5) 123 (21.4)  
65–69 44 (20.5) 91 (20.9)   65–69 9 (4.7) 28 (4.9)  
70–74 24 (11.2) 50 (11.5)   -          
          0.998           0.997
Age at blood draw (years)                      
          53–54 8 (4.2) 11 (1.9)  
55–59 19 (8.8) 34 (7.8)   55–59 65 (34.0) 199 (34.6)  
60–64 67 (31.2) 142 (32.6)   60–64 65 (34.0) 210 (36.5)  
65–69 73 (34.0) 146 (33.5)   65–69 43 (22.5) 121 (21.0)  
70–79 56 (26.1) 114 (26.2)   70–76 10 (5.2) 34 (5.9)  
          0.96           0.48
Years Between Age at Blood Draw and Case Diagnosis and Matching for Controls                      
<1 16 (7.4) 43 (9.9)   <1 14 (7.3) 37 (6.4)  
1–4 134 (62.3) 257 (58.9)   1–4 50 (26.2) 165 (28.7)  
5–9 59 (27.4) 120 (27.5)   5–9 58 (30.4) 164 (28.5)  
10–14 3 (1.4) 13 (3.0)   10–14 42 (22.0) 131 (22.8)  
15–16 3 (1.4) 3 (0.7)   15–17 27 (14.1) 78 (13.6)  
          0.48           0.95
Center                      
Colorado 10 (4.7) 39 (8.9)   Kouvola 9 (4.7) 20 (3.5)  
Georgetown 7 (3.3) 26 (6.0)   Kotka 12 (6.3) 20 (3.5)  
Henry Ford 19 (8.8) 49 (11.2)   Helsinki 63 (33.0) 160 (27.8)  
Minnesota 59 (27.4) 91 (20.9)   Jyvaskyla 11 (5.8) 52 (9.0)  
Washington 26 (12.1) 52 (11.9)   Hameenlinna 8 (4.2) 32 (5.6)  
Pittsburgh 30 (14.0) 61 (14.0)   Lahti 13 (6.8) 36 (6.3)  
Utah 22 (10.2) 40 (9.2)   Meltola 2 (1.1) 8 (1.4)  
Marshfield 39 (18.1) 66 (15.1)   Pori 8 (4.2) 29 (5.0)  
Alabama 3 (1.4) 12 (2.8)   Tampere 18 (9.4) 53 (9.2)  
            Salo 3 (1.6) 14 (2.4)  
            Seinajoki 19 (10.0) 44 (7.7)  
            Tutku 19 (10.0) 90 (15.7)  
            Rauma 6 (3.1) 17 (3.0)  
          0.19           0.44
Education                      
Less than 12 Years 16 (7.4) 17 (3.9)   Less than Elementary 6 (3.1) 16 (2.8)  
High School Graduate 58 (27.0) 96 (22.0)   Elementary School 142 (74.4) 429 (74.6)  
Post Highschool Training 31 (14.4) 56 (12.8)   Some Jr. High School 11 (5.8) 37 (6.4)  
Some College 49 (22.8) 93 (21.3)   Jr. High School 17 (8.9) 43 (7.5)  
College Graduate 37 (12.6) 80 (184)   Some Sr. High School 3 (1.6) 5 (0.9)  
Postgraduate 34 (15.8) 94 (21.6)   Sr. High School Graduate 12 (6.3) 45 (7.8)  
          0.06           0.89
History of Hypertension                      
No 124 (57.9) 304 (70.1)   No 144 (75.4) 477 (83.0)  
Yes 90 (42.1) 130 (30.0)   Yes 47 (24.6) 98 (17.0)  
          0.002           0.02
BMI (kg/m2)                      
16.7–<25 45 (20.9) 123 (28.2)   17.6–<25 57 (29.8) 211 (36.7)  
25 – <30 90 (41.9) 212 (48.6)   25 – <30 97 (50.8) 280 (48.7)  
30–62.1 80 (37.2) 101 (23.2)   30–40.4 37 (19.4) 84 (14.6)  
          0.001           0.13
Ever/Never Smoking                      
Never 190 (43.6) 95 (44.2)   Never 0 (0.0) 0 (0.0)  
Ever 246 (56.4) 120 (55.8)   Ever 191 (100.0) 575 (100.0) NA
          0.88            
Pack-Years of Smoking                      
0 95 (44.2) 190 (43.6)   -          
1–20 42 (19.5) 93 (21.3)   1–20 40 (20.9) 139 (24.2)  
21–40 34 (15.8) 65 (14.9)   21–40 83 (43.5) 284 (49.4)  
41–60 23 (10.7) 43 (9.9)   41–60 62 (32.5) 123 (21.4)  
60–200 20 (9.8) 38 (10.3)   61–113 6 (3.1) 29 (5.0)  
          0.98           0.02
Family History of Cancer                      
No 101 (47.0) 210 (48.2)   No 87 (52.4) 250 (49.9)  
Yes 114 (51.8) 226 (51.8)   Yes 79 (47.6) 251 (50.1)  
          0.78           0.58

Abbreviations: ATBC- Alpha-Tocopherol, Beta-Carotene Cancer Prevenetion Cohort; BMI- body mass index; N- number; NA- not applicable; PLCO- Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Data on family history of cancer missing from 25 cases and 74 controls in ATBC.

Data on hypertension missing from 1 case and 2 controls, diabetes status missing from 2 controls, and pack-years of smoking missing from 1 case and 7 controls in PLCO.

1

PLCO included 1 control that was randomly selected as a control twice.

2

ATBC included 151 controls that were randomly matched to more than 1 case.

3

χ2 P-value